Welcome to our dedicated page for Option Care Health news (Ticker: OPCH), a resource for investors and traders seeking the latest updates and insights on Option Care Health stock.
Option Care Health, Inc. provides home and alternate-site infusion services for patients with acute and chronic conditions across the United States. The company operates in infusion services and reports developments tied to clinical service delivery, national provider relationships, and the economics of its care model.
Recurring news for OPCH includes quarterly and full-year financial results, guidance updates, operating cash flow, share repurchase activity, credit facility changes, and presentations at health care investor conferences. Company updates also address capital allocation and management commentary related to revenue growth and profitability in home and alternate-site infusion care.
Option Care Health (OPCH) will participate in two investor conferences in New York City in September 2026, featuring its CEO and CFO.
The company is scheduled for the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026 at 10:45am ET/9:45am CT, and the Deutsche Bank 2026 Healthcare Summit on September 16, 2026. Webcast links and any presentation materials will be available on its investor relations website.
Option Care Health (Nasdaq: OPCH) reported second quarter 2026 net revenue of $1.442 billion, up 1.9% year over year. GAAP net income rose 6.7% to $53.9 million, with GAAP diluted EPS increasing 12.9% to $0.35. Adjusted EBITDA was $117.5 million, up 3.0%, and adjusted diluted EPS was $0.45, up 9.8%. The company generated $184 million of cash from Q2 operating activities and repurchased $150 million of shares during the quarter.
For full year 2026, Option Care Health expects net revenue of $5.675–$5.775 billion, adjusted diluted EPS of $1.85–$1.92, adjusted EBITDA of $480–$495 million, and at least $320 million of operating cash flow. For Q3 2026, it anticipates low- to mid-single digit sequential net revenue growth and mid-single digit sequential adjusted EBITDA growth.
Option Care Health (NASDAQ:OPCH) will release its Q2 2026 financial results on Wednesday, July 29, 2026, before the market opens. Management will host a conference call to review results at 8:30 a.m. ET the same day.
The call will be accessible via pre-registration and a live audio webcast, with a replay available for about 90 days.
Option Care Health (NASDAQ: OPCH) appointed Robert (Bob) Okunski as Vice President, Investor Relations, effective May 26, 2026. He will lead investor relations strategy, act as primary liaison with the investment community, and communicate business strategy, financial performance, capital allocation priorities and long-term growth opportunities.
Okunski previously led investor relations at Enhabit Home Health & Hospice and held senior roles at Velo3D, SunPower, Spansion and PeopleSoft. He holds an MBA from Moravian University and a BA from Colgate University.
Option Care Health (NASDAQ:OPCH) has been ranked No. 15 on the World’s Most Impactful Companies 2026 list by TIME and Statista. The ranking uses The Upright Project’s science-based Net Impact Model to assess net-positive impact across Society, Knowledge, Health, and Environment.
This third-party recognition highlights Option Care Health’s measured impact and its role as the largest independent provider of home and alternate site infusion services in the U.S., with over 8,000 team members serving patients in all 50 states.
Option Care Health (Nasdaq: OPCH) will participate in the Bank of America Health Care Conference in Las Vegas on May 12, 2026, including a fireside chat at 10:40am PT / 1:40pm ET. The event will be webcast live at the company's investor website.
The release reiterates Option Care Health's role as the nation's largest independent provider of home and alternate site infusion services, with over 8,000 team members including more than 5,000 clinicians operating in all 50 states.
Option Care Health (Nasdaq: OPCH) reported Q1 2026 results: net revenue $1,350.7M (+1.3% YoY), GAAP net income $45.3M, GAAP diluted EPS $0.29, Adjusted EBITDA $104.8M (down 6.3%), and cash used in operations $12.1M. The company repurchased $17.5M of stock and expanded its revolving credit facility to $850M. Updated full‑year 2026 guidance: revenue $5.675B–$5.775B, adjusted diluted EPS $1.82–$1.92, adjusted EBITDA $480M–$505M, and cash from operations of at least $320M.
Option Care Health (NASDAQ: OPCH) will release first-quarter 2026 results for the period ended March 31, 2026 on Thursday, April 30, 2026 before the market opens. Management will host a conference call at 8:30 a.m. ET the same day with a live audio webcast and an on-demand replay available for about 90 days.
Option Care Health (Nasdaq: OPCH) reported fourth-quarter and full-year 2025 results. Full-year net revenue rose 13.0% to $5,649.5 million and adjusted EBITDA was $471.3 million. GAAP net income was $207.6 million. The company repurchased $307 million of stock in 2025 and provided 2026 guidance.
Full-year 2026 guidance: net revenue $5.8B–$6.0B, adjusted diluted EPS $1.82–$1.92, and adjusted EBITDA $480M–$505M.
Option Care Health (Nasdaq: OPCH) will participate in the 46th Annual TD Cowen Healthcare Conference in Boston on Tuesday, March 3, 2026, including a fireside chat at 1:10 PM ET. The company will webcast the presentation at its investor site.
Option Care Health is described as the nation’s largest independent provider of home and alternate site infusion services, with over 8,000 team members and more than 5,000 clinicians serving all 50 states.